Kenneth H. Fischbeck
Hospital of the University of Pennsylvania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kenneth H. Fischbeck.
Cell | 1987
Susan Kenwrick; Mark Patterson; Astrid Speer; Kenneth H. Fischbeck; Kay E. Davies
Genetic and molecular studies show that the Duchenne muscular dystrophy (DMD) locus at Xp21 is large and complex. We have analyzed this region using pulsed field gel electrophoresis (PFGE) and have determined physical distances between Xp21 probes. The sum of the sizes of the Sfil restriction fragments detected by these probes is greater than 4000 kb. The deletion endpoints in two DMD patients were detected by observing changes in these restriction fragments. In addition, the Xp21 breakpoint for the X;1 translocation in an affected female was mapped. These results demonstrate the applicability of PFGE for analysis of Xp21, and should facilitate the mapping of other translocations and deletions in this region, some of which lead to glycerol kinase deficiency and adrenal hypoplasia as well as DMD.
Journal of Medical Genetics | 1995
David R. Lynch; Donna M. McDonald-McGinn; Elaine H. Zackai; Beverly S. Emanuel; Deborah A. Driscoll; Linton A. Whitaker; Kenneth H. Fischbeck
Velocardiofacial syndrome and DiGeorge syndrome have not previously been associated with central nervous system degeneration. We report a 34 year old man who presented for neurological evaluation with cerebellar atrophy of unknown aetiology. On historical review, he had neonatal hypocalcaemia, an atrial septal defect, and a corrected cleft palate. His physical examination showed the characteristic facies of velocardiofacial syndrome as well as dysmetria and dysdiadocho-kinesia consistent with cerebellar degeneration. Molecular cytogenetic studies showed a deletion of 22q11.2. This man is the first reported patient with the association of a neurodegenerative disorder and 22q11.2 deletion syndrome.
Journal of Medical Genetics | 1994
J Bergoffen; Jeffrey Kant; John T. Sladky; Donna M. McDonald-McGinn; Elaine H. Zackai; Kenneth H. Fischbeck
We report a rare case of paternally transmitted congenital myotonic dystrophy (DM). The proband is a 23 year old, mentally retarded male who suffers severe muscular weakness. He presented with respiratory and feeding difficulties at birth. His two sibs suffer from childhood onset DM. Their late father had the adult type of DM, with onset around 30 years. Only six other cases of paternal transmission of congenital DM have been reported recently. We review the sex related effects on transmission of congenital DM. Decreased fertility of males with adult onset DM and contraction of the repeat upon male transmission contribute to the almost absent occurrence of paternal transmission of congenital DM. Also the fathers of the reported congenitally affected children showed, on average, shorter CTG repeat lengths and hence less severe clinical symptoms than the mothers of children with congenital DM. We conclude that paternal transmission of congenital DM is rare and preferentially occurs with onset of DM past 30 years in the father.
Journal of Ultrastructure Research | 1982
Kenneth H. Fischbeck; Eduardo Bonilla; Donald L. Schotland
We studied cholesterol in mammalian muscle plasma membranes by analyzing complex formation with the sterol-specific ligand digitonin. Freeze-fracture of muscles treated with digitonin showed patches of tubular complexes that were convex on P faces and concave on E faces. We found a consistent variation in the extent of digitonin complex formation in different muscles according to the predominant fiber type. The slow-twitch soleus had a significantly greater proportion of surface area taken up by digitonin complexes than the predominantly fast-twitch extensor digitorum longus and anterior sternomastoid. This suggests that slow-twitch muscle fibers have a higher concentration of cholesterol in their plasma membrane, consistent with biochemical studies that have shown they have a greater total cholesterol content. A difference in membrane cholesterol could account for functional differences between fast- and slow-twitch muscle plasma membranes.
Neurology | 1997
David R. Lynch; H. Hara; Sabrina W. Yum; Phillip F. Chance; Steven S. Scherer; S. J. Bird; Kenneth H. Fischbeck
Hereditary motor-sensory neuropathy type III (HMSN III) (Dejerine-Sottas disease) is a severe demyelinating neuropathy that is traditionally considered autosomal recessive. We report a father and daughter diagnosed with HMSN III by clinical, electrophysiologic, and pathologic criteria, thus showing that it may be transmitted in an autosomal dominant fashion in selected families.
Advances in Experimental Medicine and Biology | 1990
Ieke B. Ginjaar; Egbert Bakker; Johan T. den Dunnen; Andy Wessels; Marleen M. B. van Paassen; Maarten D. Kloosterman; Elizabeth Zubrzycka-Gaarn; Kenneth H. Fischbeck; Antoon F.M. Moorman; Gert-Jan B. van Ommen
An immunohistochemical study was carried out on a twelve-week old fetus, aborted for high risk of Duchenne muscular dystrophy. Southern and FIGE analysis showed an intragenic duplication in the DMD gene, which had previously resulted in a severe Duchenne phenotype in three relatives. Polyclonal antibodies directed against the NH2-terminal half of dystrophin showed a positive reaction an a similar distribution of dystrophin in the skeletal myotubes of a twelve-week old normal fetus and the affected fetus. In contrast, a polyclonal antibody directed against the COOH-terminus of dystrophin, i.e., distal to the mutation in this family, did only react with the myotubes of the normal fetus and not with those of the affected fetus. This indicates the presence of a truncated dystrophin in the affected fetus. Apparently at this stage, before binding of dystrophin to the sarcolemma, no distinction is made yet between normal and abnormal dystrophins. This implies that the potential to bind to the sarcolemma could be a major point of discrimination between normal and defective dystrophins. The truncated dystrophin will probably be degraded in a later stage during fetal development. So it appears that the use of dystrophin immunostaining to confirm high Duchenne risk abortions requires great caution. To prevent false-positive results, the combined use of NH2- and COOH-terminal antibodies is mandatory.
Nature Genetics | 1992
Linda J. Valentijn; Pieter A. Bolhuis; Ina Zorn; Jessica E. Hoogendijk; N. van den Bosch; Gerard W. Hensels; V. P. Stanton; David E. Housman; Kenneth H. Fischbeck; David Ross; Garth A. Nicholson; E. J. Meershoek; Hans G. Dauwerse; G.J.B. van Ommen; Frank Baas
Annals of Neurology | 1986
Kenneth H. Fischbeck; Nada ar-Rushdi; Margaret A. Pericak-Vance; Marvin P. Rozear; Allen D. Roses; Jean-Pierre Fryns
American Journal of Medical Genetics | 1991
David H. Gutmann; Elaine H. Zackai; Donna M. McDonald-McGinn; Kenneth H. Fischbeck; John Kamholz
American Journal of Medical Genetics | 1990
David H. Gutmann; Kenneth H. Fischbeck; John Kamholz